PATENT CLAIM ANALYSIS

Application Number: 16069049
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

Claim (Index 1):
A method for preventing and/or treating ErbB2 dependent cancers, comprising:\n administering to a patient in need thereof an effective amount of a compound of following general formula (I): or a pharmaceutically acceptable salt and/or solvate thereof, wherein: X is a sulfur atom or an oxygen atom; R 1  is hydrogen atom, halo, \u2014CN, \u2014NO 2 , \u2014NO, \u2014CHO, \u2014NR 7 R 8 , \u2014CO 2 R 9 , \u2014SO 2 R 10 , \u2014SO 2 NR 11 R 12 , \u2014OR 13 , \u2014COR 14 , \u2014SR 15 , \u2014CONR 16 R 17 , \u2014SO 2 (O)R 18  or a group selected from saturated (C 1 -C 6 )alkyl, unsaturated (C 1 -C 6 )alkyl and aryl, said group being optionally substituted with one or several groups selected from halo, \u2014CF 3 , \u2014CN and \u2014SO 2 NR 19 R 20 ; R 2  and R 3  form together with the nitrogen atom to which they are chemically linked, an heterocycle or an heteroaryl group, optionally substituted with one or several groups selected from halo, \u2014CO 2 R 21  and a (C 1 -C 6 )alkyl group optionally substituted with one or several groups selected from halo, \u2014OR 22 , \u2014SR 23 , \u2014S(O)R 24 , \u2014SO 2 R 25 , \u2014SO 2 NR 26 R 27 , \u2014OC(O)R 28 , \u2014NR 29 COR 30 , \u2014NR 31 CONR 32 R 33 , \u2014NR 34 C(O)OR 35 , \u2014CO 2 R 36 , \u2014CONR 37 R 38 , \u2014OCO 2 R 39 , \u2014OCONR 40 R 41 , \u2014COR 42 , \u2014NO 2 , CF 3 , and \u2014CN; R 4 , R 5  and R 6  are, independently of one another, hydrogen atom, halo, \u2014CN, \u2014NO 2 , \u2014NO, \u2014CHO, \u2014NR 43 R 44 , \u2014CO 2 R 45 , \u2014S(O)R 46 , \u2014SO 2 R 47 , \u2014SO 2 NR 48 R 49 , \u2014OCOR 50 , \u2014NR 51 COR 52 , \u2014NR 53 CO(O)R 54 , \u2014NR 55 CONR 56 R 57 , \u2014CO 2 R 58 , \u2014OR 59 , \u2014COR 60 , \u2014SR 61 , \u2014CONR 62 R 63 , \u2014OCONR 64 R 65 , \u2014SO 2 (O)R 66 , or a group selected from saturated (C 1 -C 6 )alkyl, unsaturated (C 1 -C 6 )alkyl and aryl, said group being optionally substituted with one or several groups selected from halo, \u2014CF 3 , \u2014CN, and \u2014SO 2 NR 67 R 68 ; R 7  to R 68  are, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl, aryl or aryl(C 1 -C 6 )alkyl group, said group being optionally substituted with one or several groups selected from halo, \u2014OH, \u2014CF 3 , \u2014CN and SO 2 NR 69 R 70 ; with the proviso that R 21  is not an hydrogen atom; R 69  and R 70  are independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl, aryl or aryl(C 1 -C 6 )alkyl group; and n is an integer selected from 1 to 6.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15768388', '13497924', '15023159', '14385808', '15768257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7086118423687604
- 35 USC 102 Novelty (BERT): 0.5177724304688504
- Combined Prediction Score: 0.6895279011787694
- Mean Citation Score: 268.27641
- Max Citation Score: 282.37735
- Similarity Product: 198.3931596388072

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test